Cite
i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol
MLA
Haryana Dhillon, et al. “I-Move, a Personalised Exercise Intervention for Patients with Advanced Melanoma Receiving Immunotherapy: A Randomised Feasibility Trial Protocol.” BMJ Open, vol. 10, no. 2, Feb. 2020. EBSCOhost, https://doi.org/10.1136/bmjopen-2019-036059.
APA
Haryana Dhillon, Amelia Hyatt, Karla Gough, Andrew Murnane, George Au-Yeung, Tamara Dawson, Elizabeth Pearson, Narelle Williams, Elizabeth Paton, Alex Billett, Anya Traill, Hayley Andersen, Victoria Beedle, & Donna Milne. (2020). i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol. BMJ Open, 10(2). https://doi.org/10.1136/bmjopen-2019-036059
Chicago
Haryana Dhillon, Amelia Hyatt, Karla Gough, Andrew Murnane, George Au-Yeung, Tamara Dawson, Elizabeth Pearson, et al. 2020. “I-Move, a Personalised Exercise Intervention for Patients with Advanced Melanoma Receiving Immunotherapy: A Randomised Feasibility Trial Protocol.” BMJ Open 10 (2). doi:10.1136/bmjopen-2019-036059.